1,3-butadiene

3 papers study it2 findings

PubChem ChEBI MeSH

1 lab in 1 country

Funders: Food and Drug Administration and 5 more

Humans2
Animals1

Associations

2

PhenoAge

upin humans1

1 study

1,3-butadiene is associated with PhenoAge in humans.
“TNE-adjusted metabolites of 1,3 butadiene, ethylene oxide, and acrylonitrile were overall positively associated with Pheno-mAge”
HumansTNE-adjustedlung
Associations of volatile organic compounds with accelerated epigenetic aging in the lungs of smokers and electronic cigarette users
The Science of the total environmentMay 30, 2025

More on PhenoAge

Cancer

upin silico1

1 study

1,3-butadiene raises the risk of cancer in silico (0.2 to 600 per 10,000 workers).
“Estimates of excess risk for lifetime occupational exposure (8 h/day, 5 days/week, 50 weeks/year, for 45 years) to 2 ppm butadiene ranged from 0.2 per 10,000 workers”
In silicooccupational exposure at 2 ppm (8 h/day, 5 days/week, 50 weeks/year, for 45 years)2 ppm45 years
Time-to-tumour risk assessment for 1,3-butadiene based on exposure of mice to low doses by inhalation
IARC scientific publicationsJan 1, 1993

Latest

The Science of the Total EnvironmentJun 1

Associations of volatile organic compounds with accelerated epigenetic aging in the lungs of smokers and electronic cigarette users

Cross-sectional study in peopleLung

Environmental ResearchJun 16

Sexual dimorphism association of combined exposure to volatile organic compounds (VOC) with kidney damage

Cross-sectional study in peopleKidney disease

IARC Scientific PublicationsJan 1

Time-to-tumour risk assessment for 1,3-butadiene based on exposure of mice to low doses by inhalation

Experiments in miceBiomarkers